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AbstrACt
Objective To identify and explore change processes 
explaining the effects of the Rehabilitation Enablement 
in Chronic Heart Failure (REACH-HF) intervention taking 
account of reach, amount of intervention received, delivery 
fidelity and patient and caregiver perspectives.
Design Mixed methods process evaluation parallel 
to a randomised controlled trial using data from the 
intervention group (REACH-HF plus usual care).
setting Four centres in the UK (Birmingham, Cornwall, 
Gwent and York).
Participants People with heart failure with reduced 
ejection fraction (HFrEF) and their caregivers.
Methods The REACH-HF intervention consisted of a 
self-help manual for patients with HFrEF and caregivers 
facilitated over 12 weeks by trained healthcare 
professionals. The process evaluation used multimodal 
mixed methods analysis. Data consisted of audio recorded 
intervention sessions; demographic data; intervention 
fidelity scores for intervention group participants (107 
patients and 53 caregivers); qualitative interviews at 
4 and 12 months with a sample of 19 patients and 17 
caregivers.
Outcome measures Quantitative data: intervention 
fidelity and number, frequency and duration of intervention 
sessions received. Qualitative data: experiences and 
perspectives of intervention participants and caregivers.
results Intervention session attendance with facilitators 
was high. Fidelity scores were indicative of adequate 
quality of REACH-HF intervention delivery, although 
indicating scope for improvement in several areas. 
Intervention effectiveness was contingent on matching the 
intervention implementation to the concerns, beliefs and 
goals of participants. Behaviour change was sustained 
when shared meaning was established. Respondents’ 
comorbidities, socio-economic circumstances and existing 
networks of support also affected changes in health-
related quality of life.
Conclusions By combining longitudinal mixed methods 
data, the essential ingredients of complex interventions 
can be better identified, interrogated and tested. This can 
maximise the clinical application of research findings and 
enhance the capacity of multidisciplinary and multisite 
teams to implement the intervention.
trial registration number ISRCTN25032672; Pre-results.
IntrODuCtIOn
Heart failure (HF) is a long term condition 
associated with shortness of breath, fatigue 
and fluid retention which inhibits activities 
of daily living and leads to increased hospital-
isations and premature mortality.1 2 The prev-
alence of HF is increasing due to an ageing 
population, improved survival of people 
with HF after myocardial infarction, and 
more effective treatments for HF.3 With 
improving prognosis, the focus in HF has 
shifted towards optimising health-related 
quality of life (HRQoL). Exercise based 
strengths and limitations of this study
 ► A strength of this study is that it is underpinned 
by qualitative and quantitative systematic reviews 
conducted by a multidisciplinary and multiprofes-
sional team and, supported by a patient and public 
involvement group including people with heart fail-
ure, builds on the existing evidence base for CR 
interventions.
 ► A further strength of the study is the use of multiple 
sources of both qualitative and quantitative data to 
illustrate change processes during intervention and 
implementation practices relevant to effectiveness.
 ► An additional strength is the longitudinal data collec-
tion over 12 months.
 ► A limitation is that we did not collect data from 
the facilitator training or conduct interviews with 
facilitators.
 ► An additional limitation is that there was a limited 
number of minority ethnic participants in both the 
trial and process evaluation.
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cardiac rehabilitation (CR) in patients with HF have 
shown improvements in HRQoL and a reduction in 
hospitalisations.1
While evidence for the added value of centre and 
group based cardiac rehabillitation (CR) for patients with 
HF is strong, questions remain about the effectiveness of 
alternative modes of delivery.3 The Rehabilitation Enable-
ment in Chronic Heart Failure (REACH-HF) multicentre 
Randomised controlled trial (RCT) assessed the clinical 
effectiveness and cost-effectiveness of the addition of the 
REACH-HF intervention to usual care compared with 
usual care alone in patients with HF with reduced ejec-
tion fraction (HFrEF) and their caregivers.4 5 The patient, 
caregiver and health economic outcome results of the 
REACH-HF trial are reported elsewhere.5–7
This paper reports on a process evaluation conducted 
in parallel to the REACH-HF trial. Recent reviews of RCTs 
for HF have identified a lack of process evaluations and 
associated qualitative studies assessing change processes.8 
Indeed, prior research has failed to identify essential 
programme characteristics showing a consistent pattern 
in modifying the effects of self-management interven-
tions for people with heart failure.9 Commentators have 
also noted a failure to explain how programme elements 
of CR interventions interact10; to adequately describe the 
real world complexity of living with HF and the burden 
of both self-management and adherence to intervention 
regimens.11 The work reported here constituted part of 
the REACH-HF process evaluation that assessed interven-
tion fidelity, patients’ and caregivers’ experiences of trial 
participation and sought to identify change processes 
that may be responsible for change in HRQoL (the trial 
primary outcome).5–7
MethODs
Design
Details of the REACH-HF multicentre trial have been 
published elsewhere.4 5 In brief, 216 patients and 97 care-
givers were recruited to the trial from four geographical 
regions (Birmingham, Cornwall, Gwent and York) across 
the UK. One hundred and seven patients with 53 care-
givers were randomised to REACH-HF intervention and 
usual care (intervention group), and 109 patients and 44 
caregivers to usual care alone (control group).
A mixed methods process evaluation using linked data 
from multiple sources to build individual case studies was 
undertaken,12 paying particular attention to fidelity (the 
consistency of what was delivered with the planned inter-
vention) and adaptations (alterations made to the inter-
vention in order to achieve contextual fit)13 (figure 1). 
The intervention group formed the sampling frame for 
the process evaluation. Nineteen patients were sampled 
for maximum variation, based on their geographical 
region and their scores for the primary outcome measure 
of the trial, the Minnesota Living with Heart Failure 
Questionnaire (MLHFQ)14 and the Hospital Anxiety and 
Depression Scale.15 The four regions enabled adequate 
participant enrolment to achieve the required sample 
size and afforded the opportunity to explore local 
contexts. Sampling different scores at baseline allowed 
us to explore different longitudinal change within and 
across cases. Seventeen caregivers were also purposively 
sampled.7
reACh-hF intervention
The REACH-HF intervention is a comprehensive self-
care support programme comprising the ‘REACH-HF 
Manual,’ which includes lay explanations of HF and 
how people can learn to live with the condition to maxi-
mise their quality of life.16 It also includes a choice of 
two exercise programmes (chair based and walking); 
information about managing medications, monitoring 
fluid build-up and other symptoms (to inform appro-
priate help-seeking), and managing stress, anxiety, and 
low mood (including a relaxation CD); a ‘Family and 
Friends Resource’ for caregivers; and a participant ‘Prog-
ress Tracker’ booklet to record daily physical activity, 
symptoms and other self-care-related actions. Facilitators 
visited patients at home to introduce the programme, 
and subsequently supported patients and caregivers in 
face-to-face or telephone sessions.
Participants were required to have a first face-to-face 
contact with facilitators and at least two facilitator contacts 
thereafter, with at least one face-to-face. It was expected 
that participants would typically receive 4 to 6 contacts 
each, although the facilitators could vary the number of 
contacts as they considered necessary around this guide-
line range.
Data collection
Qualitative data: For the 19 patients who constituted 
our sampling frame (two to three patients per facilitator 
across the four regions), facilitators were required to 
audio-record all face-to face meetings with the patient 
Figure 1 Sources of data used to address process 
evaluation questions.
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(typically one 90 min and two to three 45 min sessions), 
and subsequent telephone contacts (typically three to 
six per patient). Qualitative interviews were conducted 
in peoples’ homes (or by telephone if a visit was not 
possible), and field notes collated.
Quantitative data: quantitative data were collected at 
visits to the research centre. A 13-domain fidelity check-
list was developed and piloted during the feasibility 
study, and used in the process evaluation to assess the 
facilitators’ delivery of the intervention. The checklist 
and descriptions of the intended content of the inter-
vention are published elsewhere.16The checklist items 
represented key intervention components defined by the 
intervention designers, including use of a person-cen-
tred counselling style, addressing the emotional conse-
quences of heart failure and involving caregivers in the 
intervention process. One of the intervention designers 
(JW) applied the checklist to the audio recorded inter-
vention sessions and another (CG) scored a subsample 
(around one third of the sessions). The coders compared 
and discussed the scoring to facilitate consistency. Fidelity 
scoring attributed a numerical value (0–6) for each of the 
13 domains on the fidelity checklist. Fidelity of interven-
tion was considered to be adequate if scored ≥3 for each 
domain. The score of 3 was agreed as an anchor-point for 
scoring between the coders and was interpreted for each 
domain in relation to detailed coding instructions. On 
the basis of fidelity scores (to achieve maximum diversity 
within and between patients, and where dissonance was 
identified by JW and CG), a purposive sample of audio 
recordings were used to identify examples of optimal and 
suboptimal delivery fidelity.
Patients and caregivers were contacted by the inter-
viewer and, with their consent, interviewed at 4 and 12 
months after the baseline facilitator visit. Interviews 
were conducted by experienced qualitative researchers 
and, with participant consent, audio-recorded and tran-
scribed. The interviewers followed a topic guide based on 
the objectives of both REACH-HF and the process evalu-
ation (table 1). Interviews sought to capture change over 
time.17
Data analysis
Quantitative data: using Stata V.14.2,18 descriptive statis-
tics were used to summarise the level of intervention 
received and fidelity of delivery.
Qualitative data: all available data were managed with 
Nvivo V.11 Pro.19 Individual cases were created for each 
respondent,12 including interview transcripts, contact 
sheets, audio recordings of facilitator-patient interactions 
and associated fidelity scores, summaries of the interven-
tion sessions, field notes, clinical data such as case-report 
forms, and patient reported outcome measures. Inter-
view transcripts were initially analysed using evaluative 
coding, which assigned a judgement about the merit or 
significance of the intervention from the participant’s 
perspective.20 This noted the presence or absence of 
a section of the intervention and the extent to which it 
was positively or negatively evaluated by the participant/
caregiver. Second cycle coding20 extended the mapping 
of variance across the dataset, and enabled within-case 
analyses (between patients and caregivers, and between 
4 and 12 months) and cross-case analyses (between facil-
itators and sites, and also on the basis of variables of 
interest identified in the first round, eg, gender, age and 
multimorbidities) and the further identification of direc-
tional processes.20 Fidelity was coded on the basis of the 
emphasis given to the core intended components of the 
intervention, while adaptations were coded in relation to 
the spirit of the intervention being adapted to the local 
context in order to achieve a ‘good ecological fit’.13 Data 
were anonymised and participants given pseudonyms.
Patient involvement
A patient and public involvement (PPI) group of 9 
patients and caregivers led by a lay chair cocreated the 
REACH-HF intervention, the recruitment process, and 
the associated research. Research questions and topic 
guides were developed with the group. Patient represen-
tatives shared their experiences of how their needs were 
often not considered as part of healthcare consultations, 
and advised on how to ask sensitive questions.
results
study participants
The flow of study participants is shown in figure 2. The 
characteristics of the intervention group patients who 
participated in the process evaluation are summarised in 
table 2.
Patients were predominantly male and classed as II or 
III on the New York Heart Association classification , with 
an average age of 70 years and mean left ventricular ejec-
tion fraction of 33%. Caregivers were typically the partner 
or direct relative, were of a younger mean age (63 years) 
and predominantly female. The qualitative sample was 
representative of the wider intervention group.
level of intervention received
Across the intervention group, a mean 6.5 (SD 2.6) facil-
itated sessions were provided with 4.0 (SD 1.2) being 
face-to-face contacts. A similar number of facilitated 
intervention sessions were received by the subsample of 
process evaluation participants, (total: mean 7.0, SD 2.6, 
and mean face-to-face: 4.0, SD 1.8; telephone: 2.9, SD 
2.6).
Face-to-face contacts lasted from 10 to 170 min, while 
telephone contacts ranged from 2 to 75 min. Partici-
pants in Birmingham received the lowest mean number 
of contacts (6.25, SD 1.2), and at Cornwall the highest 
mean contact (9.5, SD 3.1); the duration of contacts was 
comparable.
Fidelity of intervention delivery
Audio recordings of facilitator contacts were available for 
110 out of 322 contacts (34%). Face-to-face contacts were 
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more consistently recorded than telephone contacts, but 
there were no other obvious patterns of recording (eg, 
all of the contacts in York were recorded, but there was a 
smaller number).
Fidelity was considered to be adequate (score of ≥3 out 
of 6) in most domains (summarised in table 3).
There was room for improvement, however, particu-
larly with respect to involving the caregiver, addressing 
caregiver concerns and addressing caregiver well-being, 
where the mean scores were well below the agreed 
‘adequate’ score (table 4).
Furthermore, there was variation in fidelity scores 
across participants and facilitators. There was no discern-
ible ‘fidelity style’ for each facilitator/site (one to three 
facilitators per site) and all had participated in the 3-day 
training for the study. Six of the seven facilitators had 
nursing backgrounds (various hospital/community, reha-
bilitation/cardiac/cardiology configurations). The one 
physiotherapist had the highest fidelity scores, although 
this was too small a number of patients to be statistically 
significant.
Fidelity scores for participants in Birmingham were 
consistently higher (>3) than those for participants in 
Cornwall (<3). For all process evaluation participants, 
fidelity scores were lower in telephone contacts than with 
face-to-face consultations. Assessment of their content 
identified that they were typically more didactic in nature, 
and generally used to remind participants of key messages 
rather than to elicit or discuss any new concerns. This 
may reflect the briefer time spent in telephone sessions 
and their use as a method for briefly checking-in rather 
than raising or dealing with any more complex issues.
Table 1 Qualitative interview topic guide
Topic Questions
Opening question
Engagement with the 
intervention
First interview
Before you started, what were your expectations of the REACH-HF programme?
What did you want to know about?
Once the programme started, How did you use the manual?
Second interview Since we last spoke how have you been getting on? (Reflect on a topic recalled in that 
interview if little discussion starts—or something observed)
Relationship with REACH-HF 
facilitator
First interview
Can you describe how the facilitator worked with you?
What did you like or dislike about how the facilitator worked with you?
What did you feel about your (husband, wife, son etc) being present?
Did the facilitator help you meet your needs?
Second interview Since we last spoke have you had any further contact with the facilitator? (explore if yes)
Involvement of Family and 
Friends
Both interviews
Do you have any friends or family that help you manage your heart condition?
If so: In what way did your family or friends get involved?
How did you feel about it?
What if any discussions did you have with your family or friends about what support you 
needed from them in managing your heart failure?
Using the manual
First interview
As a result of using the manual and working with the facilitator what has changed about how 
you manage your heart failure?
What do you think about the medication section?
What do you think about the physical activity programme?
How do you plan to keep your fitness up in the future under your own steam? What other 
support might be useful?
What did you think about the progress tracker? How did you use it?
Second Interview Can you tell me about what physical activity or exercise do you do now?
What are you doing to keep track of your progress?
Processes
Both interviews
Has taking part in the intervention affected your understanding of the condition/your situation? 
If so, probe further
Has it made you feel any more or less confident about how you manage your heart failure? If 
so, probe further
Psychological adjustment to 
living with heart failure
Both interviews
Has this programme changed the way you feel about having heart failure? If so, in what way?
Has this programme changed the way you manage these feelings? If so, in what way?
What do you think about the sections of the manual that are about managing stress? Were 
these helpful? If so how? How did you monitor your progress?
Moderators and Mediators
First interview
Is there anything else that affects how you look after your heart?
Second interview What do you do now to look after your heart? Does this differ from the first interview
What other sources of information or support do you use? This is important if there are other 
heart failure management programmes being used
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The quality of delivery at the initial session with the 
facilitator set the tone for future sessions and was asso-
ciated with perceptions of intervention effectiveness, as 
two examples illustrate. Mary received one of the lowest 
amounts of REACH-HF (a total of 293 min of contact 
time, over three face-to-face and three telephone-based 
intervention sessions), but her fidelity scores were high 
(scoring ≥5 in seven of 13 domains) at the initial interven-
tion session and subsequently. The audio-recording indi-
cated that the facilitator listened to her concerns, elicited 
her goals and beliefs, and employed a range of behaviour 
change techniques, before explaining the purpose of the 
manual and resources. At 4 months Mary explained how 
the support of the facilitator combined with the walking 
programme had re-orientated her understanding of HF:
I’ve learnt a lot and I think it is a very good… manual, 
I think it’s excellent and I think, … given to people 
– I wished I’d had it right at the beginning. Because it 
has changed my attitude… (Mary: 4 months).
Her family were strongly engaged in supporting the 
intervention and created a simplified one-page progress 
tracker, which Mary used postintervention. At 12 months 
she suggested that by ‘sticking to the walking programme’ 
she was ‘feeling better in myself’ and ‘doing things 
which I couldn’t have done a year ago’. At 12 months 
her HRQoL score as assessed in terms of MLHFQ total 
score had reduced from 50 at baseline to 18, indicating a 
considerable improvement.
In contrast, Dorothy received a larger amount of 
REACH-HF (440 min over four face-to-face and two tele-
phone sessions), but fidelity scores were low at the initial 
intervention and afterwards (<2.5). Audio-recordings 
detail how the facilitator adopted a didactic approach 
with no individualised assessment. In subsequent sessions 
the facilitator failed to answer clinical questions and was 
unable to signpost Dorothy to appropriate resources. 
Dorothy’s HRQoL was good (total MLHFQ score 16) 
initially suggesting a good HRQoL, despite her having 
one of the poorest ejection fractions in the sample (21%, 
indicative of severe decompensation). Interview data 
suggests, however, her good HRQoL were due to her lack 
of insight, which was repeatedly reinforced by the poor 
facilitation of the intervention, and at 12 months there 
was no evidence of change in either understanding or 
behaviour:
I can’t seem to get the seriousness of it… [exercise] 
it is recreation, isn’t it? Mainly….it keeps, you know, 
things going…I can’t explain it really now…I did 
have a diary at first ‘cos they said keep a diary, but 
even that I don’t tend to…No, have got a bit compla-
cent… (Dorothy: 12 months)
Key processes
Analysing linked data over time12 17 enabled us to identify 
key processes that explained the effects of the REACH-HF 
intervention: adaptation, competence, comorbidities and 
social context.
Adaptation
Change was sustained when the facilitator adapted the 
intervention to participant needs. In one example, Helen 
had underlying anxiety and misconceptions about the 
need for rest, and the facilitator literally took ‘small steps’, 
walking with the participant to build capacity:
[Facilitator] said it'll, you know, it'll build your heart 
muscle up. You know, which I wasn't thinking that 
way. I was thinking: if I rest my heart and don't do any-
thing, you know, it would - you know, keep me going a 
bit longer, you know…And the more I thought about 
walking, and my heart muscle and all, the more, well, 
I thought, “Well, I'll walk, and try to get it stronger. 
(Helen: 4 months)
In contrast, where participants suggested that they had 
already acquired expertise, or had been living with HF for 
years, some facilitators struggled to engage them or tailor 
the programme effectively:
I didn't want to do [exercise]…I couldn't see the 
point in pushing myself to do it when I personally 
couldn't see I were going to get any extra benefit 
from it, as such… [Facilitator] were just doing her 
job and that were it… She weren't trying to interfere 
Figure 2 CONSORT diagram. CONSORT, consolidated 
standards of reporting trials; REACH-HF, Rehabilitation 
Enablement in Chronic Heart Failure. 
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Table 2 Baseline characteristics of patients in the intervention arm
Characteristic REACH-HF n=107 (%) Qualitative interview sample n=19 (%)
Age (years), mean (SD) 69.7 (10.9) 68.5 (9.8)
Female sex 26 (24) 7 (37)
Body Mass Index BMI (kg/m2); mean (SD) 29.5 (6.6) 31.5 (7.4)
Main activity
  Retired 81 (76) 15 (79)
  In employment or self-employment 18 (17) 2 (11)
  Unemployed 5 (5) 1 (5)
  Other 3 (3) 1 (5)
Ethnic origin
  White 100 (93) 19 (100)
  Other (Black, Asian, other) 7 (7) 0 (0)
NYHA status
  Class I 24 (22) 0 (0)
  Class II 63 (59) 13 (68)
  Class III 20 (19) 6 (32)
Ischaemic aetiology of HF 48 (45) 9 (47)
Time since diagnosis of HF (years); mean (SD) 3.6 (4.2) 3.8 (3.9)
  <1 35 (33) 6 (32)
  1–2 18 (17) 1 (5)
  2–5 28 (26) 7 (37)
  5–10 14 (13) 3 (16)
  >10 12 (11) 2 (11)
NTerminal-pro-BNP level (pg/mL); mean (SD) 1460 (1928) 1321 (1123)
Current smoker 6 (6) 1 (5)
Comorbidities (past or present)
  Diabetes mellitus 26 (24) 5 (26)
  Myocardial infarction 29 (27) 7 (37)
  Hypertension 45 (42) 9 (47)
  Chronic renal impairment 14 (13) 3 (16)
  Arthritis (osteoarthritis or rheumatoid) 45 (42) 11 (58)
  Atrial fibrillation or atrial flutter 48 (45) 9 (47)
  COPD 9 (8) 2 (11)
  Depression 27 (25) 7 (37)
Number of comorbidities
  0 63 (59) 9 (47)
  1 32 (30) 7 (37)
  2 7 (7) 1 (5)
  3 or more 5 (5) 2 (11)
Baseline use of drugs
  Beta-blocker 90 (84) 18 (5)
  Angiotensin II receptor antagonist 31 (29) 8 (42)
  ACE inhibitor 68 (64) 10 (53)
  Baseline use of devices
  Implantable cardiverter defibillator (ICD) 10 (9) 3 (16)
  Cardiac Synchronization Therapy (CRT) 10 (9) 1 (5)
Continued
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with anything. I think she, she knew she were wasting 
her time, not being rude to her. (Michael: 4mth)
Key to both fidelity and adaptation were the compe-
tences of the facilitator, the participant and their caregiver, 
the existence of comorbidities and wider contextual 
factors such as material or social deprivation.
Competence
The facilitators’ competence was key to participants’ skills 
acquisition and behaviour change. Rachel, who has post-
partum cardiomyopathy and was swimming to achieve 
the required pretransplant weight loss, explained how 
the facilitator told her that swimming was dangerous, 
although it took her ‘a few weeks to convince me though’. 
The facilitator’s challenging approach was appreciated, 
and Rachel subsequently attributed both her positive 
mental attitude and weight loss to the difficult conversa-
tions with her facilitator:
[I]t helped to have someone just there ‘cos your GPs 
busy… [GP] actually said: ‘I don’t quite know what 
to do and you’re a very rare case, and you probably 
know more about it than what I do’. You don’t want 
to hear that from a GP…Whereas [Facilitator] would 
go: ‘I’ll go back and find that out’, but she knew most 
of the answers anyway. She was very with it.(Rachel: 
12mth)
Having a friendlier and less challenging facilitator 
could, in contrast, have inhibited learning in this case. 
Post intervention, several participants without strong 
social support described how they had come to depend 
on the facilitator in a way that inhibited the development 
of self-efficacy; with some described feeling abandoned 
or isolated:
I was supposed to go in for the pacemaker and then 
they decided that I didn’t need it…I was looking for-
ward to an operation…I felt it was gonna be a bit of a 
safety net…[I feel] abandoned! [Cries]…There’s so 
many things that…turn up, just from day to day. And 
it’s usually something daft and it’s usually something 
you think: I can’t ring the doctor for that. I don’t want 
to bother them for that. So I suppose it would just be 
useful to have that contact…with someone who defi-
nitely knows what they are talking about… (Esther: 
12 month)
Where facilitators were able to use participants’ existing 
networks of health professionals and family members, 
participants expressed confidence in their newly acquired 
ability to self-manage:
I got the manual here, the big manual here. But 
they’re explaining it to me, and seeing it in black and 
white it was like ‘Oh yeah’, ‘Cos I know when you go 
down to see [Cardiac Nurse] I know they, you know, 
that she would answer questions if I asked but you’re 
always conscious of the fact that there’s a queue out-
side waiting to see her. (Mary: 4 month)
However, referrals to unfamiliar health and social care 
professionals did not always materialise, were not always 
followed up by the facilitator, and could leave participants 
feeling as though they no longer had an advocate:
Maybe I got the wrong impression…like with 
(Facilitator) and the nurses… they’ve got the title of 
heart nurses…I don’t know whether I’m allowed to 
ask them questions and whether they would get in-
volved on my behalf…I’m almost looking for the advo-
cate that says: ‘I know what you want. I’ll get it sorted.’ 
And you know…I don’t even know who to talk to…
What it really boils down to: I don’t know where…to 
go to get the information. (John:12 month)
Comorbidities
Most participants had multiple comorbidities, and some 
valued the simplicity of the REACH-HF programme, and 
specifically the accessibility of the information provided. 
Mary has arthritis, chronic back pain and breast cancer, 
and engaged with ‘simple explanations’ about medicines 
in the manual:
P: Yeah, medication, information on that, which was 
brilliant. What they are is simple explanations, there’s 
no, you know, high falutin medical jargon in there, 
Characteristic REACH-HF n=107 (%) Qualitative interview sample n=19 (%)
  Combined CRT/ICD 5 (5) 2 (11)
  Pacemaker 11 (10) 1 (5)
Location
  Cornwall 30 (28) 7 (37)
  Gwent 23 (22) 3 (16)
  Birmingham 27 (25) 4 (21)
  York 27 (25) 5 (26)
Caregiver present at randomisation 53 (50) 13 (68)
COPD, chronic obstructive pulmonary disease; HF, heart failure; NYHA, New York Heart Association.
Table 2 Continued 
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it’s basically straightforward, you read it, you under-
stand it… yes, you don’t remember the whole book, 
obviously not, but you can go back to it at any time 
that you want to, anything that crops up that you’re 
not sure of, I just go in the other room where I’ve got 
it on the table, and I open it up and read it. I don’t 
even put it away, I keep it out so that I got it there… 
(Mary: 4 months)
In contrast, Stephen, who has arthritis, diabetes and 
chronic obstructive pulmonary disease (COPD), wanted 
to ‘be a little bit fitter and a bit more active’, but his need 
to manage multiple conditions inhibited his ability to 
fully engage with the intervention:
[I’m] a little bit more active, a little bit less tired… 
But, that still remains the same, that still remains the 
major problem for me….And I’ve got knee problems 
as well so… that stops me doing a lot really. I mean 
that was the biggest thing on the walk test really, that’s 
what…curtailed things for me really…Oh the cough, 
yeah, I’ve got a cough which is… drive me around the 
bend, yeah… Most of the time, like now, it’s…. it’s just 
an annoyance, but if I get a bad cold …. it’s horren-
dous. It always ends up here, at the top of the chest 
straightaway and I’ve got about four or five weeks of 
purgatory, you know, it’s really bad. (Stephen: 4mth)
social context
Sustaining change was easier for participants with favour-
able material or social circumstances. For example, Peter 
is retired, owns his own house in a rural setting and regu-
larly plays golf as a form of gentle exercise and relaxation:
In the last 12 months I’ve been fine…we have been 
away, we went to South Africa for five weeks…we had 
a wonderful time…I am relatively fit because I go and 
play golf most days…(Peter:12 mth)
However, sustaining change was much harder for those 
with limited material or social means. Simon has COPD 
and requires oxygen therapy, but his wife smoked in the 
house and neither of them engaged with REACH-HF:
I’m one of them typical blokes: ‘Oh, it’ll be alright’… 
‘You know, I know what I’ve got, I know what’s gonna 
happen, sort of thing. But… I don’t wanna talk about, 
like, you know?’ (Simon:12 mth).
DIsCussIOn
This process evaluation increases understanding of how 
the REACH-HF intervention operated in practice, in 
terms of reach, level of intervention delivered, fidelity 
and patient perspectives. We observed that intervention 
attendance was high, with most participants receiving the 
minimum intended amount of REACH-HF. However, an 
appropriate ‘dose’ of REACH-HF is contingent on fidelity 
of intervention delivery and skilled facilitation, rather T
ab
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than the duration or frequency of contact alone. Impor-
tantly, the overall fidelity score at the initial ‘assessment’ 
session was indicative of the overall fidelity score (across 
all sessions) for an individual participant. This highlights 
the importance of the first intervention session in setting 
the tone for subsequent sessions. Intervention effective-
ness was dependent on the facilitator’s style of engage-
ment, and the extent to which the trial materials were 
matched to or adapted to the existing beliefs and goals 
of participants.21 Behaviour change was sustained when 
facilitators established shared meaning with participants. 
Respondents’ comorbidities, existing networks of support 
and socio-economic circumstances were also key to any 
changes in quality of life but, importantly in terms of 
measuring effectiveness, this may not always be reflected 
in the patient reported quantitative outcome measures. 
There was room for improvement with respect to involving 
the caregiver, and refinement of the REACH-HF interven-
tion may be now be required.7
This study has a number of strengths. First, is the ability 
to examine the implementation in detail through the use 
of a wide range of data sources, including qualitative data 
from patient interviews and facilitated contacts; observa-
tional field notes; and quantitative data about key trial 
Table 4 Number and duration of REACH-HF sessions for patients in the intervention arm
REACH-HF
(n=107)
Qualitative interview sample
(n=19)
Number of sessions per participant1; mean (SD), n; [min, max];
  Total sessions
   Overall 5.6 (2.7), 107; [0, 13] 6.5 (2.2), 19; [4, 11]
   Cornwall 6.4 (2.4), 30; [0, 12] 8.0 (2.6), 7; [4, 11]
   Gwent 5.3 (3.0), 23, [0, 12] 6.7 (2.1), 3; [5, 9]
   Birmingham 5.8 (3.3), 27; [0, 13] 6.3 (1.3), 4; [5, 8]
   York 4.6 (1.5), 27 [2, 9] 4.6 (0.5), 5; [4, 5]
  Face-to-face sessions1
   Overall 3.6 (1.4), 107; [0, 7] 3.9 (1.1), 19; [2, 7]
   Cornwall 3.1 (1.0), 30; [0, 5] 3.9 (0.7), 7; [3, 5]
   Gwent 3.9 (1.8), 23; [0, 7] 4.7 (2.1), 3; [3, 7]
   Birmingham 3.6 (1.6), 27; [0, 7] 4.0 (0.8), 4; [3, 5]
   York 3.8 (1.2), 27; [1, 7] 3.6 (1.1), 5; [2, 5]
  Telephone sessions1
   Overall 2.0 (2.1), 107; [0, 9] 2.6 (2.1), 19; [0, 7]
   Cornwall 3.4 (2.0), 30; [0, 8] 4.1 (2.4), 7; [0, 7]
   Gwent 1.4 (1.8), 23; [0, 6] 2.0 (0.0), 3; [2, 2]
   Birmingham 2.1 (2.4), 27; [0, 9] 2.3 (1.7), 4; [0, 4]
   York 0.9 (0.8), 27; [0, 3] 1.0 (0.7), 5; [0, 2]
Duration of sessions (minutes; combined across participants); mean (SD) n, [min, max]
  Face-to-face sessions1
   Overall 70 (28), 380; [15, 170] 72 (32), 75; [20, 170]
   Cornwall 75 (25), 92; [15, 145] 83 (27), 27; [30, 135]
   Gwent 69 (26), 89; [20, 160] 59 (31), 14; [20, 140]
   Birmingham 69 (33), 97; [15, 170] 76 (38), 16; [30, 170]
   York 66 (26), 102; [20, 135] 62 (28), 18; [20, 120]
  Telephone sessions1
   Overall 20 (9), 215; [2, 50] 21 (12), 50; [2, 50]
   Cornwall 21 (10), 102; [5, 50] 23 (12), 30; [5, 50]
   Gwent 14 (8), 32; [2, 33] 14 (12), 6; [2, 33]
   Birmingham 20 (9), 58; [2, 45] 17 (8), 9; [4, 28]
   York 19 (7), 23; [5, 35] 21 (10), 5; [8, 33]
REACH-HF, Rehabilitation Enablement in Chronic Heart Failure.
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processes and practice-level effectiveness. By combining 
longitudinal mixed methods data, the essential ingredi-
ents of complex interventions can be better identified, 
interrogated and tested.12 This can maximise the clinical 
application of research findings and enhance the capacity 
of multidisciplinary and multisite teams to implement the 
intervention.
Second, this research is underpinned by qualitative and 
quantitative systematic reviews conducted by a multidis-
ciplinary and multiprofessional team,1 2 supported by a 
PPI group including people with HF, and builds on the 
existing evidence base for CR interventions. Research 
has suggested that comprehensive CR interventions may 
offer added benefits over single component interven-
tions.10 11 We propose this multicomponent home-based 
CR intervention can be optimised for the patient when 
both fidelity and adaption are maximised using an initial 
rigorous personalised assessment, skilled facilitation and 
the appropriate use of programme elements.
Third, this process evaluation was conducted in parallel 
with the REACH-HF trial and has been able to investigate 
process elements and their associations with outcomes. 
Existing studies of self-management interventions for 
patients with HF (using composite or clinical endpoint 
scores) have shown limited effectiveness (ie, they could 
not identify effective programme characteristics),9 22–24 
and a criticism is that few have conducted parallel mixed 
methods process evaluations, which have the potential to 
illuminate important contextual factors, such as patient 
needs, comborbidities and social context.8 Where process 
evaluations have been conducted in relation to CR,23 
and other chronic conditions,24–27 qualitative findings 
have helped to explain the quantitative outcomes and 
suggest future directions for research. As with previous 
research,28 29 a key finding here is the dissonance between 
researchers’, physicians’ and patients’ understanding of 
HRQoL. This may account for the outcome measures 
used in trials of interventions for the self-management 
of HF not always reflecting the effectiveness of the inter-
vention at the level of the patient’s experience (as seen 
with Dorothy). Specifically, if trials of self-management 
interventions for heart failure are premised on filling the 
knowledge gaps of often elderly patients with poor health 
literacy and inhibited cognitive function, then more 
needs to be done to enable patients to express their own 
goals and values and interpretations of HRQoL in ways 
that are clinically meaningful and measurable.30–33 More 
generally, high quality process evaluations conducted 
in parallel with clinical trials have the potential to iden-
tify which interventions or elements are effective, and 
improve or eradicate those that are not.13
This study also has limitations. We did not collect data 
from the facilitator training or conduct interviews with 
facilitators. Furthermore, the facilitators did not record 
all intervention sessions or their duration as instructed, 
thus the estimated fidelity of delivery may be an over-es-
timation of the actual fidelity. This limits our insight 
into the interaction between a practitioner’s existing 
professional repertoire and their engagement with and 
delivery of REACH-HF.6 A further limitation is the small 
number of minority ethnic participants in both the trial 
and process evaluation.
More research is now required to optimise the ‘work-
ability’ of the REACH-HF intervention and integration of 
the intervention components into the facilitators’ clinical 
practice. This will ensure that fidelity and adaptation are 
maximised in the complex context of HF.30 Other studies 
that have involved facilitated interventions for HF have 
augmented facilitator training via the provision of regular 
multidisciplinary feedback,34 and the use of videocon-
ferencing and peer discussion of difficult cases.35 The 
uptake of CR is lower among people from minority ethnic 
backgrounds,36 which has been attributed to: confusion 
about the aim, structure and content of the rehabilitation 
programmes; language barriers; poor mobility; prohibi-
tive illness; distance from the rehabilitation centre; need 
for permission to attend; and lack of follow-up if a session 
was missed.37–39 More research is required to understand 
the specific support needs of people from more diverse 
ethnic backgrounds and the extent to which cultural 
beliefs may moderate or mediate the effectiveness of 
REACH-HF.
COnClusIOns
The findings of this process evaluation indicate that the 
REACH-HF intervention for patients with HFrEF and 
caregivers was adequately delivered, well received and 
could be implemented more widely. However, there was 
considerable scope for improvement, as indicated by the 
fidelity scores and in-depth qualitative analysis. Behaviour 
change appeared to be sustained when shared meaning 
between the participant and facilitator was established, 
although patients’ comorbidities, socio-economic circum-
stances and existing networks of support were key to any 
changes in HRQoL, which may not always be reflected 
in quantitative outcome measures. For example, where 
a facilitator was able to elicit a participant perspective, 
and tailor the intervention accordingly, this was often 
contingent on the nature of the wider contextual issues: 
if a ‘problem’ was within the scope of the intervention 
or facilitator (ie, anxiety) then tailoring was appropriate 
although fidelity could be compromised. However, if the 
problem was not within scope (ie, socio-economic disad-
vantage), then tailoring was more difficult. More now 
needs to be done to ensure fidelity and identify those 
patients for whom effectiveness may be more difficult to 
achieve.
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